Clinical Trial Update: Pharmacokinetics of Mmf and Valganciclovir [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of mycophenolate mofetil and valganciclovir in kidney and heart transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation
• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Valcyte (valganciclovir)

Snippet

Sponsor: University of Michigan | Conditions: Kidney Transplant Recipient, Heart Transplant Recipient | Phase 4 | Status: COMPLETED